Clevidipine vs Placebo or Standard of Care for Dyspnea and Blood Pressure Control in AHF
Status:
Withdrawn
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate dyspnea improvement and other parameters of efficacy
and safety in acute heart failure (AHF) patients receiving an intravenous (IV) infusion of
clevidipine in comparison to standard of care (SOC) and placebo.